22nd Century Group, Inc. (XXII), a next-generation plant biotechnology company, was featured in a Washington Post article on Tuesday, discussing the U.S. FDA's proposed policy to reduce nicotine content in cigarettes.
The policy, which recently passed a review by the Office of Management and Budget, could benefit an estimated 13 million smokers in its first five years.
The article emphasizes the potential of 22nd Century's VLN reduced nicotine content cigarettes to help smokers control their nicotine intake.
VLN cigarettes are the first and only combustible tobacco products authorized by the FDA under its Modified Risk Tobacco Product designation.
These products, which contain 95% less nicotine than traditional cigarettes, are already available in more than 5,000 stores across the U.S.
Larry Firestone, CEO of 22nd Century, expressed optimism about the FDA's policy, noting that it represents one of the most impactful smoking harm reduction strategies in recent history.
The company continues to expand the availability of its VLN products and aims to demonstrate the effectiveness of reduced nicotine content cigarettes in helping smokers reduce their nicotine consumption.
Currently, XXII is trading at $7.34 up by 20.83%.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.